Historical record - last NADAC effective date: 9/22/2021
Product Information
OMEGA-3 ETHYL ESTERS 1 GM CAP is a generic product labeled by Par Pharmaceutical Inc., priced at $0.1926 per EA under NDC 00254301008. Its NADAC has been published 147 times since Dec 12, 2018.
FDA first approved this application on Sep 19, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Omega-3-acid ethyl esters market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
900 mg/1
Manufacturer
Par Pharmaceutical Inc.NDC
00254301008
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/22/2021
Active Ingredients
OMEGA-3-ACID ETHYL ESTERSApproval Type
Generic (ANDA)
FDA Application
ANDA203893FDA Approved
9/19/2017
TE Code
AB
On Market Since
9/19/2017
Pharmacological Classes
Price Statistics
The NADAC for OMEGA-3 ETHYL ESTERS 1 GM CAP has been published 147 times since Dec 12, 2018, and over the history we have for it it has declined 26.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1926 per EA |
|---|---|
| All-time high | $0.2890 (Sep 11, 2019) |
| All-time low | $0.1737 (Jun 23, 2021) |
| Median price | $0.2505 |
| Average price | $0.2397 |
| Largest weekly change | -19.9% (Mar 17, 2021) |
| Weeks tracked | 147 |
| Tracking since | Dec 12, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-26.9%
Last surveyed Sep 29, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Omega-3-acid ethyl esters market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Par Pharmaceutical Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Omega-3-acid ethyl esters market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Omega-3 Fatty Acid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OMEGA-3 ETHYL ESTERS 1 GM CAP?
The current National Average Drug Acquisition Cost (NADAC) for OMEGA-3 ETHYL ESTERS 1 GM CAP, manufactured by Par Pharmaceutical Inc., is $0.1926 per EA (NDC 00254301008), effective Sep 29, 2021.
How has the price of OMEGA-3 ETHYL ESTERS 1 GM CAP changed over time?
Over the history we have for it, the NADAC for OMEGA-3 ETHYL ESTERS 1 GM CAP has declined 26.9%. It has been tracked across 147 weekly CMS publications since Dec 12, 2018.
What are the highest and lowest recorded NADAC prices for OMEGA-3 ETHYL ESTERS 1 GM CAP?
Since Dec 12, 2018, the NADAC for OMEGA-3 ETHYL ESTERS 1 GM CAP has ranged from a low of $0.1737 (Jun 23, 2021) to a high of $0.2890 (Sep 11, 2019), with a median of $0.2505 per EA.
Are there cheaper alternatives to OMEGA-3 ETHYL ESTERS 1 GM CAP?
No other NADAC-published product currently shares the active ingredient and strength of OMEGA-3 ETHYL ESTERS 1 GM CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OMEGA-3 ETHYL ESTERS 1 GM CAP?
OMEGA-3 ETHYL ESTERS 1 GM CAP (NDC 00254301008) is labeled by Par Pharmaceutical Inc., and CMS classifies it as a generic product.